Market News

Rain Enhancement Technologies Secures Second U.S. Installation with Utah Permit Approval, Advances Snow Enhancement Capabilities

Company’s WETA Ionization Technology Begins Operations in Grand County, Utah, Marking State’s First Ionization-Based Weather Modification Program NAPLES, FL / ACCESS Newswire / November 18, 2025 / Rain Enhancement Technologies Holdco, Inc. (NASDAQ:RAIN) (“RAIN” or the “Company”), a […]

News Feed

Rain Enhancement Technologies Strengthens Strategic Leadership with Quantum Physics Pioneer and Corporate Governance Expert

NASDAQ-Listed Company Adds Two Distinguished Advisors with Complementary Expertise NAPLES, FL / ACCESS Newswire / October 15, 2025 / Rain Enhancement Technologies Holdco, Inc. (NASDAQ:RAIN) (“RET” or the “Company”), a leading provider of ionization rainfall generation technology, today […]

News Feed

Terra Clean’s Fraser Lakes B Deposit Contains Significant Rare Earth Element Potential and is Listed as an Active Government of Canada Rare Earth Deposit

Vancouver B.C., October 15, 2025 – TERRA CLEAN ENERGY CORP. (“Terra” or the “Company”) (CSE: TCEC, OTCQB: TCEFF, FSE: C9O0, is pleased to highlight the rare earth element (“REE”) potential at its Fraser Lakes B Deposit,confirmed by drilling and assays. The REE component within the deposit and surrounding areas contains significant quantities of rare […]

News Feed

Soligenix Achieves Important Safety Milestone in its Confirmatory Phase 3 Clinical Trial of HyBryte™ for the Treatment of Cutaneous T-Cell Lymphoma

FLASH 2 Study Interim Efficacy Analysis Targeted for 1H2026 Enrollment Update Remains on Track for 4Q2025 PRINCETON, N.J., Oct. 7, 2025 /PRNewswire/ — Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and […]

News Feed

Soligenix Announces Publication Describing Long-Term High Temperature Stability of Protein Subunit Vaccines for Ebola and Related Viruses

Two Year Stability demonstrated in both bivalent and trivalent configurations at temperatures of 40°C / 104°F PRINCETON, N.J., Sept. 4, 2025 /PRNewswire/ — Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on […]